Although investor concerns about the MedTech Sector have been based on expected declines in obesity rates with the surging adoption of GLP-1s, IQVIA MedTechs analysis of the data tells a different story, overall, that - to date - obesity diagnoses remain stable during the rise of GLP-1 uptake as depicted below: As a result, the resilience of obesity diagnosis occurring despite the rising uptake of GLP-1s should serve as a positive general signal for MedTech industry players to counter investor concerns about the potential of reduced demand, or that the demand may be net-neutral, rather than a sudden decline
The science behind how LifeWave patches work, why the X39 patch changed everything for the company, what phototherapy actually does for the body, and exactly how to use the patches correctly
But I like crazy notions The American actor speaks to Louis Chilton about his own origin story, why Six Feet Under was the black-sheep sibling of The Sopranos, and his delightful return as the murderous Mr Morgan in the new Dexter revival Bookmark CommentsGo to comments It was never part of any mission statement I had, insists Michael C Hall, playing characters who are, in one way or another, surrounded by dead bodies. He smiles, shrewdly
However, no GLP-1 patch has received FDA approval, and scientific evidence supporting their effectiveness remains absent
Donald Douglas, R-Nicholasville, is the sponsor of Senate Bill 72, a bill he described as a commonsense approach to provide parity for health care professionals
3.6 Innovative potential and clinical translation of DDS Current advancements in machine learning, bioinformatics, and multi-omics technologies have enabled significant progress in targeted precision interventions for cancer (Shao et al., 2025